{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:47:29Z","timestamp":1792169249708,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PPRPGM-Nov20\\100002"],"award-info":[{"award-number":["PPRPGM-Nov20\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["SEBCD3-2024\/100001"],"award-info":[{"award-number":["SEBCD3-2024\/100001"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDAMC-2023\/100004"],"award-info":[{"award-number":["EDDAMC-2023\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR305827"],"award-info":[{"award-number":["NIHR305827"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>National guidelines recommend English women between 30 and 49 years with moderate\/high risk of breast cancer (BC) be offered screening and prevention interventions. Identification \u00a0largely\u00a0relies on family history-based criteria amongst women self-presenting in primary care. We aimed to understand the preference for different potential risk assessment strategies in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional survey including a discrete choice experiment. Risk assessments were defined using six attributes, including initiation strategy, eligibility for a full\/detailed risk assessment, components of the risk assessment, including multifactorial risk assessment based on the BOADICEA\/CanRisk model, and sensitivity. Coefficients from conditional logistic regression were used to estimate preference for different risk assessment approaches compared to current care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009893) preferred alternative approaches for risk assessments over current care, particularly where all eligible women were proactively invited and more above-average risk women were correctly identified. All but one of 21 risk assessment approaches was preferred, with the most favoured approaches having a probability of being preferred over current care &gt;92%. Education level and ethnicity potentially impacted the strength of participant priorities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Offering multifactorial BC risk assessments to younger women in primary care, especially the most proactive and broad approaches, would be acceptable and preferred over current practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03546-3","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:01:27Z","timestamp":1785805287000},"page":"1430-1438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Priorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-0723","authenticated-orcid":false,"given":"Rebecca A.","family":"Dennison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-9731","authenticated-orcid":false,"given":"Maria","family":"Valasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4064-7998","authenticated-orcid":false,"given":"Stuart","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-6515","authenticated-orcid":false,"given":"Sacha J.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-3247","authenticated-orcid":false,"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-3563","authenticated-orcid":false,"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garcia-Closas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria G.","family":"Woof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-7804","authenticated-orcid":false,"given":"David P.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-2531","authenticated-orcid":false,"given":"Juliet A.","family":"Usher-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3546_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"3546_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010.","journal-title":"Breast"},{"key":"3546_CR3","doi-asserted-by":"publisher","first-page":"E2353331","DOI":"10.1001\/jamanetworkopen.2023.53331","volume":"7","author":"S Xu","year":"2024","unstructured":"Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status. JAMA Netw Open. 2024;7:E2353331 https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.53331.","journal-title":"JAMA Netw Open"},{"key":"3546_CR4","doi-asserted-by":"publisher","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049.","DOI":"10.1136\/bmjonc-2023-000049"},{"key":"3546_CR5","unstructured":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (CG164) National Institute for Health and Care Excellence. 2013. https:\/\/www.nice.org.uk\/guidance\/cg164"},{"key":"3546_CR6","doi-asserted-by":"publisher","unstructured":"Grimm LJ, Avery CS, Hendrick E, Baker JA. Benefits and risks of mammography screening in women ages 40 to 49 years. J Prim Care Community Health 2022;13. https:\/\/doi.org\/10.1177\/21501327211058322.","DOI":"10.1177\/21501327211058322"},{"key":"3546_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1940-6207.CAPR-14-0037","volume":"7","author":"DG Evans","year":"2014","unstructured":"Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, et al. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res. 2014;7:993\u20131001. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0037.","journal-title":"Cancer Prev Res"},{"key":"3546_CR8","doi-asserted-by":"publisher","unstructured":"Usher-Smith JA, Tooth G, Follows A, Badran AR, Youngs A, Forman A, et al. Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancer. BJC Rep. 2024;2. https:\/\/doi.org\/10.1038\/s44276-023-00027-5.","DOI":"10.1038\/s44276-023-00027-5"},{"key":"3546_CR9","doi-asserted-by":"publisher","unstructured":"Frost R, Ficorella L, Berrington de Gonzale A, Antoniou AC, Garcia-Closas M, Usher-Smith JA, et al. Comparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50 within primary care. Br J Cancer. 2026. https:\/\/doi.org\/10.1038\/s41416-026-03547-2.","DOI":"10.1038\/s41416-026-03547-2"},{"key":"3546_CR10","doi-asserted-by":"publisher","unstructured":"Valasaki M, Taylor LC, Woof VG, Howell SJ, Tischkowitz M, Antoniou AC, et al. The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improve. Br J Cancer 2026. https:\/\/doi.org\/10.1038\/S41416-025-03329-2.","DOI":"10.1038\/S41416-025-03329-2"},{"key":"3546_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jmedgenet-2022-108471","volume":"59","author":"A Lee","year":"2022","unstructured":"Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet. 2022;59:1206\u201318. https:\/\/doi.org\/10.1136\/jmedgenet-2022-108471.","journal-title":"J Med Genet"},{"key":"3546_CR12","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21:1708\u201318. https:\/\/doi.org\/10.1038\/s41436-018-0406-9.","journal-title":"Genet Med"},{"key":"3546_CR13","doi-asserted-by":"publisher","unstructured":"Dennison R, Morris S, Clune RJ, Wright S, Waller J, Usher-Smith J. Risk-based innovations in cancer screening and diagnosis: a discrete choice experiment to explore priorities of the UK public. BMJ Open 2025;15. https:\/\/doi.org\/10.1136\/BMJOPEN-2024-093803.","DOI":"10.1136\/BMJOPEN-2024-093803"},{"key":"3546_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41416-023-02268-0","volume":"129","author":"L McWilliams","year":"2023","unstructured":"McWilliams L, Ruane H, Ulph F, Woof VG, Harrison F, Evans DG, et al. What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study. Br J Cancer. 2023;129:356\u201365. https:\/\/doi.org\/10.1038\/s41416-023-02268-0.","journal-title":"Br J Cancer"},{"key":"3546_CR15","doi-asserted-by":"publisher","unstructured":"Kelley-jones C, Scott S, Waller J. UK women\u2019s views of the concepts of personalised breast cancer risk assessment and risk-stratified breast screening: a qualitative interview study. Cancers 2021;13. https:\/\/doi.org\/10.3390\/cancers13225813.","DOI":"10.3390\/cancers13225813"},{"key":"3546_CR16","doi-asserted-by":"publisher","unstructured":"Hindmarch S, Howell SJ, Usher-Smith JA, Gorman L, Evans DG, French DP. Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30-39 years: a mixed-methods study protocol. BMJ Open 2024;14. https:\/\/doi.org\/10.1136\/bmjopen-2023-078555.","DOI":"10.1136\/bmjopen-2023-078555"},{"key":"3546_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","volume":"32","author":"MD Clark","year":"2014","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32:883\u2013902. https:\/\/doi.org\/10.1007\/s40273-014-0170-x.","journal-title":"Pharmacoeconomics"},{"key":"3546_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","volume":"26","author":"E Lancsar","year":"2008","unstructured":"Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics. 2008;26:661\u201377. https:\/\/doi.org\/10.2165\/00019053-200826080-00004.","journal-title":"Pharmacoeconomics"},{"key":"3546_CR19","unstructured":"Orme B. Sample size issues for conjoint analysis studies. Sequim: Sawtooth Software Technical Paper 1998."},{"key":"3546_CR20","unstructured":"Johnson R, Orme B. Getting the Most from CBC. Sawtooth software research paper series. Sawtooth Software, Sequim 2003."},{"key":"3546_CR21","doi-asserted-by":"publisher","unstructured":"Hindmarch S, Gorman L, Hawkes RE, Howell SJ, French DP. Optimising the delivery of breast cancer risk assessment for women aged 30\u201339 years: a qualitative study of women\u2019s views. Women\u2019s Health 2023;19. https:\/\/doi.org\/10.1177\/17455057231160348.","DOI":"10.1177\/17455057231160348"},{"key":"3546_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/BJC.2011.337","volume":"105","author":"AJ Swerdlow","year":"2011","unstructured":"Swerdlow AJ, Jones ME, Schoemaker MJ, Hemming J, Thomas D, Williamson J, et al. The breakthrough generations study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br J Cancer. 2011;105:911\u20137. https:\/\/doi.org\/10.1038\/BJC.2011.337.","journal-title":"Br J Cancer"},{"key":"3546_CR23","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/CNCR.34365","volume":"128","author":"DD Durham","year":"2022","unstructured":"Durham DD, Abraham LA, Roberts MC, Khan CP, Smith RA, Kerlikowske K, et al. Breast cancer incidence among women with a family history of breast cancer by relative\u2019s age at diagnosis. Cancer. 2022;128:4232\u201340. https:\/\/doi.org\/10.1002\/CNCR.34365.","journal-title":"Cancer"},{"key":"3546_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10689-020-00188-z","volume":"20","author":"N Qureshi","year":"2021","unstructured":"Qureshi N, Dutton B, Weng S, Sheehan C, Chorley W, Robertson JFR, et al. Improving primary care identification of familial breast cancer risk using proactive invitation and decision support. Fam Cancer. 2021;20:13\u201321. https:\/\/doi.org\/10.1007\/s10689-020-00188-z.","journal-title":"Fam Cancer"},{"key":"3546_CR25","doi-asserted-by":"publisher","first-page":"e0336902","DOI":"10.1371\/journal.pone.0336902","volume":"20","author":"F Stutzin Donoso","year":"2025","unstructured":"Stutzin Donoso F, Archer S, Walter FM, Morris S, Emery J, Broome J, et al. CanRisk-GP protocol: a feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice. PLoS ONE. 2025;20:e0336902 https:\/\/doi.org\/10.1371\/journal.pone.0336902.","journal-title":"PLoS ONE"},{"key":"3546_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:1\u201313. https:\/\/doi.org\/10.1186\/s12913-017-2031-8.","journal-title":"BMC Health Serv Res"},{"key":"3546_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-022-07577-3","volume":"22","author":"M Sekhon","year":"2022","unstructured":"Sekhon M, Cartwright M, Francis JJ. Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions. BMC Health Serv Res. 2022;22:1\u201312. https:\/\/doi.org\/10.1186\/s12913-022-07577-3.","journal-title":"BMC Health Serv Res"},{"key":"3546_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CGM, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19:300\u201315. https:\/\/doi.org\/10.1016\/j.jval.2016.04.004.","journal-title":"Value Health"},{"key":"3546_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08347-w","volume":"21","author":"L McWilliams","year":"2021","unstructured":"McWilliams L, Woof VG, Donnelly LS, Howell A, Evans DG, French DP. Extending screening intervals for women at low risk of breast cancer: do they find it acceptable? BMC Cancer. 2021;21:637. https:\/\/doi.org\/10.1186\/s12885-021-08347-w.","journal-title":"BMC Cancer"},{"key":"3546_CR30","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.3390\/cancers13225813","volume":"13","author":"C Kelley-Jones","year":"2021","unstructured":"Kelley-Jones C, Scott S, Waller J. UK women\u2019s views of the concepts of personalised breast cancer risk assessment and risk-stratified breast screening: a qualitative interview study. Cancers. 2021;13:5813 https:\/\/doi.org\/10.3390\/cancers13225813.","journal-title":"Cancers"},{"key":"3546_CR31","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/hex.13522","volume":"25","author":"RA Dennison","year":"2022","unstructured":"Dennison RA, Boscott RA, Thomas R, Griffin SJ, Harrison H, John SD, et al. A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening. Health Expect. 2022;25:1789\u2013806. https:\/\/doi.org\/10.1111\/hex.13522.","journal-title":"Health Expect"},{"key":"3546_CR32","doi-asserted-by":"publisher","unstructured":"Dennison RA, Clune RJ, Tung JSL, Schumacher AA, Solovyeva M, Pandey P, et al. The public are receptive to risk-based innovations: a multi-methods exploration of anticipated acceptability and uptake of novel technologies for cancer early detection in symptomatic and asymptomatic scenarios. Front Cancer Control Soc 2025;3. https:\/\/doi.org\/10.3389\/fcacs.2025.1522609.","DOI":"10.3389\/fcacs.2025.1522609"},{"key":"3546_CR33","doi-asserted-by":"publisher","unstructured":"Dennison RA, Wright S, Lyratzopoulos G, Pashayan N, Morris S, Nicholson B, et al. Public (un)willingness to trade-off benefits and harms in decisions about cancer screening: a discrete choice experiment. J Med Screen. 2026. https:\/\/doi.org\/10.1177\/09691413261422933.","DOI":"10.1177\/09691413261422933"},{"key":"3546_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pec.2019.08.010","volume":"103","author":"M Bayne","year":"2020","unstructured":"Bayne M, Fairey M, Silarova B, Griffin SJ, Sharp SJ, Klein WMP, et al. Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: a systematic review and meta-analysis. Patient Educ Couns. 2020;103:83\u201395. https:\/\/doi.org\/10.1016\/j.pec.2019.08.010.","journal-title":"Patient Educ Couns"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03546-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03546-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:22Z","timestamp":1792166242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03546-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03546-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ACA is listed as a creator of the BOADICEA v.6 model which has been licensed by Cambridge Enterprise (University of Cambridge). All other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}